Showing results (701-710 of 1,738) with videos related to

Sort By:
Pageof 174
Harm Reduction Journal|April 8, 2018
Expanding harm reduction to include fentanyl urine testing: results from a pilot in rural British ColumbiaSilvina C Mema, Chloe Sage, Serge Popoff, et al.
Harm Reduction Journal|July 12, 2017
A qualitative assessment of an abstinence-oriented therapeutic community for prisoners with substance use disorders in KyrgyzstanLyuba Azbel, Julia Rozanova, Ingo Michels, et al.
Harm Reduction Journal|April 18, 2018
Origins in the USA in the 1980s of the warning that smokeless tobacco is not a safe alternative to cigarettes: a historical, documents-based assessment with implications for comparative warnings on less harmful tobacco/nicotine productsLynn T Kozlowski
Harm Reduction Journal|June 2, 2018
The "here and now" of youth: the meanings of smoking for sexual and gender minority youthTamar M J Antin, Geoffrey Hunt, Emile Sanders
Harm Reduction Journal|July 1, 2020
The impact of cigarette and e-cigarette use history on transition patterns: a longitudinal analysis of the population assessment of tobacco and health (PATH) study, 2013-2015Lai Wei, Raheema S Muhammad-Kah, Thaddaeus Hannel, et al.
Harm Reduction Journal|July 4, 2014
Are empty methadone bottles empty? An analytic studyGaël Dupuy, Lia Cavalcanti, Emmanuel Bourgogne, et al.
Harm Reduction Journal|February 22, 2023
'I'm not going to leave someone to die': carriage of naloxone by police in Scotland within a public health framework: a qualitative study of acceptability and experiencesElizabeth M Speakman, Peter Hillen, Inga Heyman, et al.
Harm Reduction Journal|March 9, 2023
Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven surveySarah Brothers, Adam Palayew, Caty Simon, et al.
Harm Reduction Journal|April 24, 2015
Acquiring hepatitis C in prison: the social organisation of injecting riskCarla Treloar, Luke McCredie, Andrew R Lloyd, et al.
Harm Reduction Journal|August 10, 2022
Opioid agonist treatment take-home doses ('carries'): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?Cayley Russell, Shannon Lange, Fiona Kouyoumdjian, et al.
Pageof 174